À propos
*Do what you can't*
Co-founder at Wandercraft. We develop and make Calvin, the…
Co-founder at Wandercraft. We develop and make Calvin, the…
Articles de Jean-Louis
-
Did Wandercraft find the Holy Grail of robotics ?
Did Wandercraft find the Holy Grail of robotics ?
Articles from Engadget, ZDNet, L'Obs or Le Monde claim that Wandercraft has found the Holy Grail of robotics :…
6 commentaires -
@ FrenchTech with all the gang, and the President.
@ FrenchTech with all the gang, and the President.
1 commentaire
Activité
15 k abonnés
-
Jean-Louis Constanza a republié ceciJean-Louis Constanza a republié ceciScientists invent World's first Self-Balancing Exoskeleton That Lets Wheelchair Users Stand and Move Hands-Free In a quiet but consequential moment for mobility technology, a Paris-based robotics company has brought something long promised into everyday American homes. On 17 September 2026, Wandercraft commercially Launched 'Eve', the world’s first FDA-cleared self-balancing personal exoskeleton. Eve is Designed for eligible adults with spinal cord injury at any neurological level, Eve allows users to stand and walk upright without crutches or a walker, keeping their hands free for ordinary tasks like reaching for a cup, opening a door, preparing food, or simply holding a conversation at eye level. Source: https://lnkd.in/p/dkmRdg9M
-
Jean-Louis Constanza a republié ceciJean-Louis Constanza a republié ceci16 patients with spinal cord injury tested Wandercraft's Eve exoskeleton. All 16 hit their mobility goals, zero serious adverse events. It just became the first FDA-cleared, self-balancing exoskeleton approved for home use, no crutches required. Robotics is leaving the rehab gym for the living room. #MedTech #HealthTech #Robotics
-
Jean-Louis Constanza a republié ceciJean-Louis Constanza a republié ceciFrench robotics company Wandercraft has launched Eve, a personal exoskeleton designed to help eligible wheelchair users with spinal cord injuries stand and walk while keeping both hands free. Eve uses powered hip, knee and ankle joints with 12 actuated degrees of freedom, combined with a self-balancing system that allows users to walk without relying on crutches or a walker for balance. The device has received FDA clearance, supported by three clinical studies involving 39 people with spinal cord injuries. The FDA reported that Eve met its primary effectiveness and usability targets, while the studies recorded 25 device- or procedure-related adverse events, all classified as non-serious and resolved without lasting effects. Eve can accommodate eligible users up to 100 kg (220 lb) and 1.94 m (6’4”), depending on fitting requirements. It can reach speeds of up to 0.9 km/h and typically provides around four hours of battery life. However, Eve is not a replacement for a wheelchair and has specific operating limitations. It is intended for suitable flat, firm and dry surfaces, and users must have a specially trained companion within arm’s reach during operation. Before taking Eve home, users and their companions complete five training sessions of approximately two hours each. Wandercraft describes Eve as the world’s first FDA-cleared self-balancing personal exoskeleton, potentially opening new possibilities for everyday standing and walking for eligible wheelchair users. Source: U.S. Food and Drug Administration; Wandercraft Disclaimer: This post is based on information from the FDA and Wandercraft. Eve is intended only for eligible users who meet the device’s medical, physical and fitting requirements, and its use is subject to specific safety restrictions and training. #Wandercraft #EveExoskeleton #Robotics #Exoskeleton #MedicalRobotics #SpinalCordInjury #Accessibility #AssistiveTechnology #HealthcareTechnology #ArtificialIntelligence #TechNews #RoboticsNews #Innovation #FutureOfMobility #MedTech
-
Jean-Louis Constanza a partagé ceciForget Opus 5.x, Le Chat, Muse, the GPTs and the rest. This is a milestone. The AI trained on *you* Presented like an assistant for you But Ask yourself. Someone whom you like very much trains Sentience (the Ai's name). The AI acquires a very strong resemblance. The person passes away. Will you want to keep her/him 'with you' ? Won't you ? Are you sure ? Think again. Now, run this AI in a really good robot... https://lnkd.in/e9KKNzuT
-
Jean-Louis Constanza a partagé ceciWandercraft’s vision, for our robot Calvin to be the 1st #humanoid to deploy in real production, is gaining traction ! Robots are made to work in factories and take on strenuous jobs - not to perform spectacular kung-fu shows ;)Jean-Louis Constanza a partagé ceci𝗨𝗻 𝗿𝗼𝗯𝗼𝘁 𝗵𝘂𝗺𝗮𝗻𝗼𝗶̈𝗱𝗲 𝗾𝘂𝗶 𝘁𝗿𝗮𝘃𝗮𝗶𝗹𝗹𝗲 𝟰𝟬 𝗷𝗼𝘂𝗿𝘀 𝗱'𝗮𝗳𝗳𝗶𝗹𝗲́𝗲 𝗲𝗻 𝗽𝗼𝗿𝘁𝗮𝗻𝘁 𝟰𝟬 𝗸𝗴. 𝗖𝗲 𝗻'𝗲𝘀𝘁 𝗽𝗮𝘀 𝘂𝗻 𝗽𝗿𝗼𝘁𝗼𝘁𝘆𝗽𝗲 𝗱𝗲 𝘀𝗮𝗹𝗼𝗻, 𝗰'𝗲𝘀𝘁 𝘂𝗻𝗲 𝗽𝗿𝗲𝗺𝗶𝗲̀𝗿𝗲 𝗲𝘂𝗿𝗼𝗽𝗲́𝗲𝗻𝗻𝗲, 𝗲𝗻 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻. Présentée au Tech For Industry Show 2026, la keynote Renault Group × Wandercraft a détaillé le cas du robot Calvin, conçu en un temps record et pensé pour un poste réel, pénible pour l'humain. L'objectif affiché est ambitieux, plusieurs centaines de robots à horizon 2027. La vraie rupture n'est pas le robot lui-même, mais sa capacité à s'adapter à un environnement d'usine variable. Et l'intention est claire, sortir les opérateurs des tâches les plus dures, pas supprimer des postes. L'humanoïde en usine n'est plus une promesse, c'est un premier pas déjà franchi. Lire l’article en entier : urlr.me/mhx6y2 Tech For Industry Show revient les 19 et 20 mai 2027. Jean-Louis Constanza, eric Marchiol, Francois Lavernos, Anne-Sophie LANDIER, Cécile MANDONNET-DUPIC, Caroline de Beaumont, Melissa Serfaty, Karen Serfaty, Kathleen de La Malène, Emma Metairy
-
Jean-Louis Constanza a republié ceciJean-Louis Constanza a republié ceciToday is the day! 🎉 Join Wandercraft at 6pm EST, for the live launch of Eve™, the world’s first FDA-cleared self-balancing personal exoskeleton, which makes hands-free upright mobility available to eligible wheelchair users living with spinal cord injuries at any level, who can manually operate the device’s controller. NSM is proud to be Eve’s exclusive Complex Rehabilitation Technology (CRT) distribution partner, and our CEO, Crispin Teufel, will be speaking during tonight’s livestream. We’re excited to celebrate this incredible milestone together! ��Learn more here: https://bit.ly/46uWlSG 👉 Register for the livestream here: https://bit.ly/3Tac0DC 🗓️ See you tonight at 6pm EST!
-
Jean-Louis Constanza a partagé ceciThis is why we wake up every morning at WandercraftJean-Louis Constanza a partagé ceci🇫🇷 Vous ne verrez rien de plus beau aujourd'hui ❤️ Touchée par la maladie de Charcot, Pauline Messier a pu remarcher pour la première fois depuis deux ans grâce à un exosquelette 🤩 Une magnifique invention signée Wandercraft.
-
Jean-Louis Constanza a republié ceciJean-Louis Constanza a republié ceciIl y a quelques années, cette scène aurait ressemblé à de la science-fiction. Aujourd’hui, elle existe. Sur cette photo, un homme se déplace grâce à un exosquelette développé par Wandercraft, une entreprise française spécialisée dans la robotique médicale. Le principe est impressionnant : l’exosquelette motorisé accompagne les mouvements des jambes et gère une partie de l’équilibre pour permettre à certaines personnes atteintes de troubles neurologiques ou de lésions médullaires de se lever, tenir debout et marcher dans le cadre de leur rééducation. Et derrière la technologie, il y a surtout quelque chose de beaucoup plus fort. Se remettre debout. Faire quelques pas. Regarder les autres à hauteur d’homme. Retrouver des sensations qu’on pensait parfois perdues. On parle beaucoup d’intelligence artificielle, de robots, de technologies du futur… Mais les innovations les plus impressionnantes sont peut-être celles qui réussissent simplement à rendre à quelqu’un une partie de ce que la vie lui avait retiré. Et ça, c’est une technologie qui a du sens. ineosa.com
-
Jean-Louis Constanza a partagé ceciWe at Wandercraft just revealed our massive commercial success since we started to commercialize our #humanoid Cavin, one year ago. Read Matthieu Masselin's take below. Deploying #humanoid robots with 12 very large customers, in industry or logistics. Who benchmarked us against most competitors from China, the USA and Europe. Fast progression in both hardware and physical AI. Owning our data. First order of 350 robots for true industrial use, a premiere in Europe and maybe elsewhere. There is no reason to fear the upcoming and intense competition in robots. We in Europe, especially Wandercraft, with our partner Renault Group, have everything to win it. And that is because we deliver what our customers are wanting: high reliability, high success rate, heavy payloads, independent sovereignty of our production. No frills, no kung-fu, only industrial features. We Europeans must make our own robots ! We're working on it. ** Read more about our path toward commercial dominance in industrial humanoids: https://lnkd.in/g6eRHBWq **Jean-Louis Constanza a partagé ceci12 blue-chip customers. Real-world deployments. And our industrial humanoid Calvin-40 is just getting started.�� Across automotive, retail, healthcare facilities, defense logistics, and other industries, customers are turning to Calvin-40 for physically demanding work - from handling tires to boxes and parcels. Our approach to physical AI is deliberate: establish reliability across commercially valuable task clusters, deploy Calvin-40 in real-world environments, and use data and experience from those deployments to progress toward general purpose robotics. Just as important, we control the learning loop. Wandercraft owns the operational data, use-case expertise, and the development path from reliable task-specific performance to broader generalization, independent of any single technology supplier. Humanoid robots will not scale because they are general. They will become general as they scale. Read more about our path toward commercial dominance in industrial humanoids: https://lnkd.in/g6eRHBWq
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceciScientists invent World's first Self-Balancing Exoskeleton That Lets Wheelchair Users Stand and Move Hands-Free In a quiet but consequential moment for mobility technology, a Paris-based robotics company has brought something long promised into everyday American homes. On 17 September 2026, Wandercraft commercially Launched 'Eve', the world’s first FDA-cleared self-balancing personal exoskeleton. Eve is Designed for eligible adults with spinal cord injury at any neurological level, Eve allows users to stand and walk upright without crutches or a walker, keeping their hands free for ordinary tasks like reaching for a cup, opening a door, preparing food, or simply holding a conversation at eye level. Source: https://lnkd.in/p/dkmRdg9M
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceciUne publication scientifique met en lumière les résultats très positifs de BUDDY The Emotional Robot auprès des enfants hospitalisés. Présenté à la Conférence #Handicap2026, l’article croise deux expériences de téléprésence : #TEDi, qui permet à des élèves absents pour raisons de santé de retrouver leur classe, et #BuddyGuard, qui aide des enfants hospitalisés au CHU de Toulouse à garder le contact avec leur famille. Les observations montrent que l’enjeu va bien au-delà de la continuité des cours : 🤝 Retrouver ses camarades. Dans TED-i, le maintien du lien social apparaît comme un besoin majeur des enfants. 🏠 Rester présent auprès de sa famille. Avec Buddy Guard, l’enfant hospitalisé peut explorer son domicile à distance et interagir avec sa fratrie. 🚶 Participer à la vie autour de soi. La mobilité du robot permet des échanges spontanés et donne à l’enfant une place dans les lieux dont il est éloigné. 💙 Une expérience que les participants souhaitent renouveler. Dans le retour d’expérience TED-i rapporté par les chercheurs, 90 % des parties prenantes interrogées retenteraient l’aventure avec #Buddy Ces résultats nous encouragent à poursuivre notre travail avec les équipes éducatives, les soignants et les familles. L’article identifie aussi les progrès nécessaires pour faciliter les déploiements, notamment sur la connexion, la mise en place et l’accompagnement des utilisateurs. Merci notamment à Rémi Izoulet qui s'est particulièrement engagé dans le projet Buddy Guard et qui a largement contribué à cet article aux cotés de Aurélie Clodic Nolwenn Gauer Margo Biret Laurent Gallon Ophélie Carreras Anke Brock et Gwenaël Kaminski Vous accompagnez des enfants éloignés de leur école ou de leur famille pour raisons de santé ? Échangeons sur ce que #Buddy pourrait leur apporter : sales@bluefrogrobotics.com , www.bluefrogrobotics.com Lire la publication : https://lnkd.in/euf9h234 BLUE FROG ROBOTICS LAAS-CNRS ENAC - Ecole Nationale de l'Aviation CivileLaboratoire Informatique de l'Université de Pau et des Pays de l'Adour (LIUPPA) Université Toulouse - Jean Jaurès Laboratoire de Psychologie et de NeuroCognition @cognition langue #Buddy #Téléprésence #Inclusion #Éducation #Santé #Robotique #aiforgood #robotforgood
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceciLe véritable risque pour notre industrie n'est pas la robotisation, c'est la dépendance technologique. L'autre jour, j'écoutais une interview de Jean-Louis Constanza de Wandercraft qui a résumé l'urgence avec lucidité : « [...] trouver le moyen que la France ne soit pas cliente de la Chine ou des autres pays pour ses robots, ça c'est fondamental hein, parce que si vous payez les Chinois pour tenir un emploi qui aurait dû être tenu par un Français, vous avez perdu deux fois. Et les pays qui ne seront pas maîtres de la technologie des robots sont des pays déclassés, rapidement déclassés. » C'est au moment de créer des preuves de concept et d'engager la réflexion sur les robots humanoïdes qu'il faut se poser les questions de souveraineté. La France et l'Europe ne peuvent pas se contenter d'être un simple marché d'importation. C'est une de nos mission chez Robotics Valley, fédérer notre écosystème pour bâtir et déployer une filière robotique française souveraine.
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceciMark Raymond, Jr. stood on stage in Eve to deliver his speech at this year’s Show of Love Gala, with our own Katherine Broderick by his side. 💜 The evening in New Orleans marked ten years since the diving accident that left Mark paralyzed and inspired the creation of the Split Second Foundation. Today, its work supports aging adults and people living with paralysis and mobility impairments. Eve, our FDA-cleared personal exoskeleton, is now commercially available in the US for eligible adults with spinal cord injuries. Its self-balancing technology enables upright mobility without crutches or a walker, leaving users’ hands free for everyday activities. Bringing that mobility beyond rehabilitation and into people’s lives is what Eve is about. Seeing Mark address his community in Eve, with his parents joining him on stage, made that purpose feel especially close. Thank you, Mark and the Split Second team, for including us in such a meaningful evening. We’re proud to celebrate alongside you. 👥 : Mark Raymond, Jr., Katherine Broderick, Sophie Pellas, Split Second Foundation.
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceci16 patients with spinal cord injury tested Wandercraft's Eve exoskeleton. All 16 hit their mobility goals, zero serious adverse events. It just became the first FDA-cleared, self-balancing exoskeleton approved for home use, no crutches required. Robotics is leaving the rehab gym for the living room. #MedTech #HealthTech #Robotics
-
Jean-Louis Constanza a aimé ceciJean-Louis Constanza a aimé ceciFrench robotics company Wandercraft has launched Eve, a personal exoskeleton designed to help eligible wheelchair users with spinal cord injuries stand and walk while keeping both hands free. Eve uses powered hip, knee and ankle joints with 12 actuated degrees of freedom, combined with a self-balancing system that allows users to walk without relying on crutches or a walker for balance. The device has received FDA clearance, supported by three clinical studies involving 39 people with spinal cord injuries. The FDA reported that Eve met its primary effectiveness and usability targets, while the studies recorded 25 device- or procedure-related adverse events, all classified as non-serious and resolved without lasting effects. Eve can accommodate eligible users up to 100 kg (220 lb) and 1.94 m (6’4”), depending on fitting requirements. It can reach speeds of up to 0.9 km/h and typically provides around four hours of battery life. However, Eve is not a replacement for a wheelchair and has specific operating limitations. It is intended for suitable flat, firm and dry surfaces, and users must have a specially trained companion within arm’s reach during operation. Before taking Eve home, users and their companions complete five training sessions of approximately two hours each. Wandercraft describes Eve as the world’s first FDA-cleared self-balancing personal exoskeleton, potentially opening new possibilities for everyday standing and walking for eligible wheelchair users. Source: U.S. Food and Drug Administration; Wandercraft Disclaimer: This post is based on information from the FDA and Wandercraft. Eve is intended only for eligible users who meet the device’s medical, physical and fitting requirements, and its use is subject to specific safety restrictions and training. #Wandercraft #EveExoskeleton #Robotics #Exoskeleton #MedicalRobotics #SpinalCordInjury #Accessibility #AssistiveTechnology #HealthcareTechnology #ArtificialIntelligence #TechNews #RoboticsNews #Innovation #FutureOfMobility #MedTech